Quantitative analysis for Avalyn Pharma Inc. Common Stock (AVLN) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Hold (51.0) (grade C). 29 signals analyzed (23 differentiated alt-data).
AVLN stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-30 | $30.20 | $26.00 | $29.49 |
| 2026-05-12 | $31.02 | $29.25 | $29.90 |
| 2026-05-22 | $29.67 | $26.68 | $28.84 |
| 2026-06-04 | $28.00 | $25.71 | $26.99 |
| 2026-06-16 | $29.78 | $28.00 | $28.07 |
| 2026-06-29 | $32.24 | $30.29 | $31.00 |
| 2026-07-10 | $28.67 | $27.12 | $28.06 |
| 2026-07-22 | $30.45 | $28.25 | $28.72 |
| 2026-08-03 | $29.33 | $27.78 | $28.08 |
| 2026-08-14 | $39.47 | $35.07 | $39.25 |
| 2026-08-26 | $38.37 | $36.44 | $37.04 |
How Avalyn Pharma Inc. Common Stock stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| MLTX | MoonLake Immunotherapeutics | $1.3B | — |
| CMPS | COMPASS Pathways plc | $1.0B | — |
| ALVO | Alvotech | $1.0B | — |
| BTX | BlackRock Technology and Private Equity Term Trust | $1.0B | — |
View all Health Care stocks by valuation and signals →
Avalyn Pharma Inc. Common Stock (AVLN) scores Hold (51.0), with every measured dimension at or below 57. The weakest are competitive moat at 27, analyst consensus at 9, across 4 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| ML forecast | 57 |
| technicals | 53 |
| competitive moat | 27 |
| analyst consensus | 9 |
StoQuant analyzes 29 signals (23 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Avalyn Pharma Inc. Common Stock (AVLN): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/AVLN"><img src="https://stoquant.com/badge/AVLN.svg" alt="Avalyn Pharma Inc. Common Stock (AVLN) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.